Related Blog Posts
Genetic Variations Indicate Risk Of Recurrence, Secondary Cancer Among Head And Neck Cancer Patients
1 day ago ago from The Cancer Foundation For The World
Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference Read Full Article
Related contentLoneliness makes cancer ‘more likely and deadly’
19 hours ago ago from AXXA News
Fresh evidence adds weight to suggestions that loneliness makes cancer both more likely and deadly. Work in Proceedings of the National Academy of Science shows social isolation tips the odds in favour of aggressive cancer growth. Rodents kept alone developed more tumours - and tumours of a more deadly type - than rats living as a group. The researchers put it down to stress and say the same may well be true in humans. ...
Related contentA new mouse could help understand how some lung cancer cells evade drug treatment
4 hours ago ago from Science-Query.com » Science News
Lung cancer is the leading cause of cancer mortality worldwide and lung adenocarcinoma is the most common type. Many cases of lung adenocarcinoma are attributed to a mutation in a gene for the epidermal growth factor receptor (EGFR). Lung cancer with changes in EGFR is initially treatable with a family of chemotherapeutic agents called tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib. However, patients often develop ...
Related contentPistachios may reduce lung cancer risk – Genetic Engineering News
18 hours ago ago from Diet Guide Site
HOUSTON A diet that incorporates a daily dose of pistachios may help reduce the risk of lung and other cancers, according to data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec Original Post By Google News Click Here For The Entire Article
Related contentReview of Major Advances in Clinical Cancer Research in 2009
12 hours ago ago from CMU Medical Education and Techology Review
Review of Major Advances in Clinical Cancer Research in 2009 Zosia Chustecka Medscape Medical News © 2009 Medscape, LLC This year's annual report on clinical cancer advances from the America Society of Clinical Oncology (ASCO) highlights 15 studies described as major advances and 51 studies considered to be notable advances. Each of the studies highlighted has significantly altered the way a cancer is understood or had an ...
Related contentRelated News
Pennsylvania Residents Tested for Rare Blood Cancer
16 hours ago ago from FOX News
Pennsylvania Residents Tested for Rare Blood Cancer Tuesday, December 08, 2009 Print ALLENTOWN, Pa. Federal health researchers have tested nearly 2,200 people in northeastern Pennsylvania for a genetic mutation associated with a rare blood cancer. The testing found the mutation in 19 people, or 1.6 percent of those who participated in the study. Scientists don't yet know how prevalent this mutation is in the general population. The ...
Related contentWant to Cut Cancer Risk? Try Munching Pistachios
5 hours ago ago from Forbes.com
WEDNESDAY, Dec. 9 (HealthDay News) -- Eating pistachios every day might reduce your risk for lung cancer and other malignancies, according to a new study. Pistachios are a good source of a type of vitamin E called gamma-tocopherol. It is known that vitamin E provides a degree of protection against certain forms of cancer. Higher intakes of gamma-tocopherol ... may reduce the risk of lung cancer, Ladia M. Hernandez, a senior research ...
Related contentThe Group Room® Features Live Videocast from San Antonio Breast Cancer Symposium
18 hours ago ago from Good News Now
The Group Room cancer talk show, produced by Vital Options International , will take place live from the 32 nd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) , December 11, 2009, 1-3pm CT , Room 218, and for the first time features a live videocast . This year marks a decade that Vital Options has produced The Group Room from SABCS, the largest international gatherings of clinicians and scientists in the field of breast cancer, ...
Related contentResearch Shows Efforts To Quit Smoking Strengthen After Personalized Lung Cancer Risk Test
18 hours ago ago from Good News Now
Smokers who see their own personal risk of developing lung cancer after genetic-based testing show stronger intention and take more action on quitting smoking, according to clinical trial results presented to an American Association of Cancer Research conference. The pilot study looked at smokers’ response to taking the Respiragene TM test, which combines genetic and non-genetic factors to show smokers and ex-smokers their own risk of lung ...
Related contentCritical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics
4 hours ago ago from FanHouse
HOUSTON, Dec. 9 /PRNewswire-FirstCall/ -- Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today announced that it has signed an exclusive License Agreement with Wayne State University to key intellectual property covering discoveries of biomarkers of ovarian cancer. The agreement with Wayne State University grants Arrayit exclusive worldwide rights to develop and commercialize a novel ...
Related contentRelated Videos
